Literature DB >> 19850021

Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism.

Enzo Emanuele1, Paolo Orsi, Francesco Barale, Stefania Ucelli di Nemi, Marco Bertona, Pierluigi Politi.   

Abstract

OBJECTIVE: To study vascular endothelial growth factor (VEGF) and its soluble receptors sVEGFR-1 and -2 in autism. DESIGN AND METHODS: We measured serum levels of angiogenic molecules in 22 patients with severe autism and 28 controls.
RESULTS: Patients and controls had similar sVEGFR-2 levels, but VEGF levels were lower and sVEGFR-1 higher in patients with autism.
CONCLUSION: The imbalance between VEGF and its receptor sVEGFR-1 may be involved in the pathophysiology of autism. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850021     DOI: 10.1016/j.clinbiochem.2009.10.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers.

Authors:  Ni Fan; Minling Zhang; Ke Xu; Xiaoyin Ke; Yi Ding; Daping Wang; Yuping Liu; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Drug Alcohol Depend       Date:  2015-05-08       Impact factor: 4.492

3.  Early generalized overgrowth in boys with autism.

Authors:  Katarzyna Chawarska; Daniel Campbell; Lisha Chen; Frederick Shic; Ami Klin; Joseph Chang
Journal:  Arch Gen Psychiatry       Date:  2011-10

4.  Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.

Authors:  Paulo L Lizano; Jeffrey K Yao; Neeraj Tandon; Suraj Sarvode Mothi; Debra M Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2016-11-15       Impact factor: 4.939

5.  Traffic-related particulate matter affects behavior, inflammation, and neural integrity in a developmental rodent model.

Authors:  Benjamin C Nephew; Alexandra Nemeth; Neelakshi Hudda; Gillian Beamer; Phyllis Mann; Jocelyn Petitto; Ryan Cali; Marcelo Febo; Praveen Kulkarni; Guillaume Poirier; Jean King; John L Durant; Doug Brugge
Journal:  Environ Res       Date:  2020-02-17       Impact factor: 6.498

6.  Comparison of Serum VEGF, IGF-1, and HIF-1α Levels in Children with Autism Spectrum Disorder and Healthy Controls.

Authors:  Fulya Şimşek; Ümit Işık; Evrim Aktepe; Faruk Kılıç; Fevziye Burcu Şirin; Mustafa Bozkurt
Journal:  J Autism Dev Disord       Date:  2021-01-03

7.  DIA1R is an X-linked gene related to Deleted In Autism-1.

Authors:  Azhari Aziz; Sean P Harrop; Naomi E Bishop
Journal:  PLoS One       Date:  2011-01-17       Impact factor: 3.240

Review 8.  An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism.

Authors:  Pere Berbel; Daniela Navarro; Gustavo C Román
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-09       Impact factor: 5.555

9.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.

Authors:  C J Carter
Journal:  J Pathog       Date:  2013-03-04

10.  Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders.

Authors:  Jordan M Ramsey; Paul C Guest; Jantine Ac Broek; Jeffrey C Glennon; Nanda Rommelse; Barbara Franke; Hassan Rahmoune; Jan K Buitelaar; Sabine Bahn
Journal:  Mol Autism       Date:  2013-08-06       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.